Pharmaceuticals, Biotechnology and Life Sciences
New York City Economic Development Corporation Chooses Chicago-based MATTER to Bring Together New York Scientists, Entrepreneurs and Leading Companies to…
Phase-1b/2 Clinical Data for Aura’s Lead Asset, AU-011, to be Highlighted at the Meeting and at Other Related Events CAMBRIDGE,…
DULUTH, Ga.–(BUSINESS WIRE)–The intersection of technology and medicine has never been more important, and the theme of the Georgia Bio…
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Robots Market to 2027 – Global Analysis and Forecasts by Product, by Application, by End User and…
DUBLIN–(BUSINESS WIRE)–The “Hematology Drugs Global Market Forecast To 2022” report has been added to ResearchAndMarkets.com’s offering. Where is the largest…
– Including Cefiderocol Phase III APEKS-NP Trial as Late-breaker Oral Presentation – OSAKA, Japan & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Shionogi &…
cTAP has published a comprehensive analysis of the North Star Ambulatory Assessment (NSAA), a newly adopted primary outcome measure in clinical trials of patients with Duchenne Muscular Dystrophy.
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Preparations Market In Hungary” report has been added to ResearchAndMarkets.com’s offering. This report is dedicated to the…
PARIS–(BUSINESS WIRE)–Regulatory News: Lysogene (FR0013233475 – LYS) (Paris:LYS), a pioneering Phase 3 biopharmaceutical company specializing in gene therapy targeting central…
Join us at a cocktail reception, The View Lounge, San Francisco Marriott Marquis, Tuesday, 7 p.m.-11 p.m., Oct. 1, 2019,…